EV/EBITDA
-0.24
0.000.00%
75 min ago
Summary:
Evoke Pharma EV/EBITDA is currently -0.24, unchanged from the previous trading day. Over the past year, it has increased by +0.17 (+41.46%). EVOK EV/EBITDA is now -164.86% below its all-time high of 0.37.EVOK EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EVOK EV/EBITDA Performance
| PeriodPeriod | EV/EBITDAEV/EBITDA |
|---|---|
| todaytoday | 0.0% |
| 1 m1 month | -2500.0% |
| 3 m3 months | -2300.0% |
| 6 m6 months | -200.0% |
| ytdytd | +53.9% |
| 1 y1 year | +41.5% |
| 5 y5 years | +94.0% |
EVOK EV/EBITDA High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | 0.04 | -700.0% | -0.24 | at low |
| 3 m | 3 months | 0.37 | -164.9% | -0.41 | +41.5% |
| 6 m | 6 months | 0.37 | -164.9% | -0.41 | +41.5% |
| 1 y | 1 year | 0.37 | -164.9% | -0.86 | +72.1% |
| 3 y | 3 years | 0.37 | -164.9% | -3.37 | +92.9% |
| 5 y | 5 years | 0.37 | -164.9% | -12.92 | +98.1% |
| alltime | all time | 0.37 | -164.9% | -34.33 | +99.3% |
Evoke Pharma EV/EBITDA History
| Date | Value |
|---|---|
| 2024 | -0.24(-53.8%) |
| 2023 | -0.52(-5.5%) |
| 2022 | -0.55(-68.0%) |
| 2021 | -1.72(-65.9%) |
| 2020 | -5.05(+5.6%) |
| 2019 | -4.78(+1.1%) |
| Date | Value |
|---|---|
| 2018 | -4.73(+95.5%) |
| 2017 | -2.42(+60.3%) |
| 2016 | -1.51(-8.5%) |
| 2015 | -1.65(-17.1%) |
| 2014 | -1.99(-77.9%) |
| 2013 | -9.02 |
FAQ
- What is Evoke Pharma EV/EBITDA?
- What is the all time high EV/EBITDA for Evoke Pharma?
- What is EVOK EV/EBITDA year-to-date change?
- What is Evoke Pharma EV/EBITDA year-on-year change?
What is Evoke Pharma EV/EBITDA?
The current EV/EBITDA of EVOK is -0.24
What is the all time high EV/EBITDA for Evoke Pharma?
Evoke Pharma all-time high EV/EBITDA is 0.37
What is EVOK EV/EBITDA year-to-date change?
Evoke Pharma EV/EBITDA has changed by +0.28 (+53.85%) since the beginning of the year
What is Evoke Pharma EV/EBITDA year-on-year change?
Over the past year, EVOK EV/EBITDA has changed by +0.17 (+41.46%)